Answers are grounded in this paper and cite their sources.
Retrospective analysis reveals significant apnea–hypopnea index reduction in positional obstructive sleep apnea patients, indicating HNS therapy effectiveness.
Background: Obstructive sleep apnea (OSA) is a prevalent disorder characterized by airway collapse during sleep. Continuous positive airway pressure (CPAP) is first-line treatment but adherence can decay over time due to intolerance. Hypoglossal nerve stimulation (HNS) has emerged as an alternative, especially for CPAP-intolerant patients. OSA can be classified into position-dependent (PD-OSA) and non-position-dependent (NPD-OSA) subtypes based on apnea–hypopnea index (AHI) variation by sleep posture. Study Objectives: This study aims to evaluate polysomnographic changes following HNS therapy and compare treatment outcomes in PD-OSA and NPD-OSA patients. Methods: A retrospective observational study of 30 patients treated with HNS at a single center between January 2022 and March 2025 was conducted. The primary endpoint was change in overall apnea–hypopnea index (AHI) from baseline to first post-implant in-laboratory polysomnography (PSG). Secondary endpoints included changes in phenotype-specific (supine and non-supine) AHI, Epworth Sleepiness Scale (ESS), and sleep architecture parameters. Subgroup comparisons were performed between PD-OSA and NPD-OSA phenotypes. Results: Thirty patients (median age 69.5 years; 73% male; median BMI 28.9 kg/m2) were included; 27 had sufficient positional data for phenotype classification (66.7% PD-OSA, 33.3% NPD-OSA). Median AHI decreased from 23.5 to 4.8 events/h (p < 0.0001), with reductions in both REM and supine AHI. PD-OSA patients demonstrated the greatest improvement in supine AHI, whereas NPD-OSA patients uniquely improved in non-supine AHI. ESS decreased by a median of 1.5 points overall (p = 0.0015) and met the minimal clinically important difference in NPD-OSA. Sleep architecture showed minimal change, except for a reduction in supine sleep percentage (p = 0.0114). Conclusions: HNS therapy improved AHI and subjective sleepiness across OSA phenotypes, with distinct positional responses. These findings support the clinical utility of HNS in both PD-OSA and NPD-OSA and suggest phenotype-specific treatment effects warrant further investigation.
No takes yet. Share an insight, caveat, or question.
Hernández et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: